PACB icon

Pacific Biosciences
PACB

Overview Fund Activity

225 hedge funds and large institutions have $475M invested in Pacific Biosciences in 2024 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 75 increasing their positions, 65 reducing their positions, and 35 closing their positions.

Holders
225
Holders Change
-1
Holders Change %
-0.44%
% of All Funds
3%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
38
Increased
75
Reduced
65
Closed
35
Calls
$6.83M
Puts
$4.17M
Net Calls
+$2.65M
Net Calls Change
+$2.97M

Top Buyers

1
SoftBank Group
1
SoftBank Group
Japan
$37.4M
2
Millennium Management
2
Millennium Management
New York
$31.2M
3
T. Rowe Price Investment Management
3
T. Rowe Price Investment Management
Maryland
$8.96M
4
AIM
4
ARK Investment Management
Florida
$66M
5
Morgan Stanley
5
Morgan Stanley
New York
$10.3M

Top Sellers

1
Capital World Investors
1
Capital World Investors
California
$0
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$27.9M
3
Jane Street
3
Jane Street
New York
$780K
4
Marshall Wace
4
Marshall Wace
United Kingdom
$93.1K
5
Sumitomo Mitsui Trust Group
5
Sumitomo Mitsui Trust Group
Japan
$18.6M
Name Market Value Shares Shares
Change 		Shares
Change %
AIM
1
ARK Investment Management
Florida
$66M 36,044,362 +2,637,961 +8%
BlackRock
2
BlackRock
New York
$45M 24,594,773 +1,342,091 +6%
MA
3
Madrone Advisors
California
$42.8M 23,391,915 – –
EDRH
4
Edmond de Rothschild Holding
Switzerland
$39.1M 21,346,480 +1,038,600 +5%
SoftBank Group
5
SoftBank Group
Japan
$37.4M 20,451,570 +20,451,570 New
Millennium Management
6
Millennium Management
New York
$31.2M 17,065,331 +6,642,753 +64%
Vanguard Group
7
Vanguard Group
Pennsylvania
$27.9M 15,226,858 -2,415,946 -14%
Sumitomo Mitsui Trust Group
8
Sumitomo Mitsui Trust Group
Japan
$18.6M 10,178,501 -1,687,265 -14%
NAMA
9
Nikko Asset Management Americas
New York
$18.4M 10,178,501 -1,687,265 -14%
State Street
10
State Street
Massachusetts
$11.8M 6,426,975 +150,819 +2%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$11.5M 6,262,925 -64,981 -1%
Morgan Stanley
12
Morgan Stanley
New York
$10.3M 5,651,558 +1,759,016 +45%
Bank of New York Mellon
13
Bank of New York Mellon
New York
$9.52M 5,203,967 -369,200 -7%
JSP
14
Jackson Square Partners
California
$9.35M 5,109,266 -1,186,850 -19%
T. Rowe Price Investment Management
15
T. Rowe Price Investment Management
Maryland
$8.96M 4,896,844 +4,896,844 New
Goldman Sachs
16
Goldman Sachs
New York
$8.77M 4,792,776 +554,509 +13%
Northern Trust
17
Northern Trust
Illinois
$4.6M 2,514,824 +157,145 +7%
SFM
18
Soros Fund Management
New York
$4.34M 2,372,265 +274,265 +13%
Bank of America
19
Bank of America
North Carolina
$4.05M 2,214,513 -139,334 -6%
Charles Schwab
20
Charles Schwab
California
$3.98M 2,176,252 +135,949 +7%
KOC
21
Koss-Olinger Consulting
Florida
$3.66M 2,000,000 +1,200,000 +150%
Walleye Capital
22
Walleye Capital
New York
$3.56M 1,943,046 +1,698,931 +696%
T. Rowe Price Associates
23
T. Rowe Price Associates
Maryland
$3.24M 1,771,653 -67,099 -4%
Barclays
24
Barclays
United Kingdom
$3.04M 1,660,059 +1,064,909 +179%
UBS Group
25
UBS Group
Switzerland
$2.72M 1,486,015 +843,166 +131%
1
2 3 4 5